PIEB Compared With CEI on Breakthrough Pain in Nulliparous Women
ConditionBreakthrough Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorHoly Family Hospital, Nazareth, Israel
About this trial
The goal of this randomized controlled trial is to examine the impact of programmed intermittent bolus epidural analgesia technique on the incidence of breakthrough pain during labor in nulliparous women compared to continuous epidural infusion.
Nulliparous women will randomly be divided during labor into two groups; study group will receive mix of Bupivacaine and fentanyl once (bolus) every 60 minutes; the control group will receive continuously the same dose during an hour, until delivery.
Eligibility criteria
Qualifiers
Nulliparous women
Term pregnancy
Singleton
Vertex presentation
Disqualifiers
Estimated fetal weight > 4 kg
Intra uterine fetal death
Drug sensitivity
Anomalous fetus
Trial design
Treatments tested in this trial
- programmed intermittent Bolus epidural analgesia
- continuous epidural infusion
Treatment groups
240 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov